Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

SHA:688578 Revenue

Shanghai Allist Pharmaceuticals had revenue of 1.74B CNY in the quarter ending June 30, 2026, with 36.12% growth. This brings the company's revenue in the last twelve months to 6.13B, up 40.83% year-over-year. In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.19B with 45.80% growth.

• Revenue (ttm): 6.13B
• Revenue Growth: +40.83%
• P/S Ratio: 8.55
• Revenue / Employee: 2.70M
• Employees: 1,989
• Market Cap: 52.43B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.19B	1.63B	45.80%
Dec 31, 2024	3.56B	1.54B	76.29%
Dec 31, 2023	2.02B	1.23B	155.14%
Dec 31, 2022	791.00M	260.91M	49.22%
Dec 31, 2021	530.09M	529.53M	94,409.97%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error